Health & Medicine
COVID-19: US and Japan Start Gilead's Remdesivir Treatment Days after Emergency Approval of Drug
The treatment of Gilead Sciences Inc. for patients severely ill with COVID-19 in Japan has begun days after granting emergency approval to the medication.
Latest Research Articles
Apples, Berries and Tea Could Protect You From Alzheimer's Disease
Mysterious Coronavirus-Related Illness in Children: Warning Signs to Look For
-
How Can Clean Air Purifiers Improve Sleep?
-
The Way Forward: What it Could Take to Reopen in COVID-19's Wake
-
5 Ways Stress Can Impact Your Natural Good Looks
-
Psychological Trauma: COVID-19 Health Workers Next Problem?
-
2020 Pandemic: How is Quarantine Affecting Social Health?
-
Emergency Use of Gilead's Remdesivir Authorized by the FDA for COVID-19 Treatment
-
3-Week-Old Infant with Severe Case of COVID-19 Successfully Treated by Health Experts
-
Jenner Institute and Astra Zeneca at the Forefront in the Race for COVID-19 Vaccine
-
New Insights in Asthma Medicines May Improve Future Drugs and Treatment
-
Why Med Students “Fail” USMLE® Step 1 (and How to Make Sure You Pass the First Time)
MOST POPULAR
-
Legionaire's Disease Outbreak In UK Update: Symptoms To Watch Out As 25 People Now Infected
-
The Truth Behind the Piper Alpha Disaster - What Really Happened in the North Sea Incident That Took 167 Lives?
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
